Gurnet Point Capital provides capital, ideas, and commercial expertise to a select group of life science companies. The firm will invest in venture-stage companies with promising scientific innovations and growth- and buyout-ready opportunities with revenue and potential. Through Gurnet's venture investments, the firm will invest $500K to upwards of $20M in seed and traditional venture rounds. Through growth buyouts, Gurnet will make investments ranging from double-digit millions to $1 billion or more.